Association with Aurora-A Controls N-MYC-Dependent Promoter Escape and Pause Release of RNA Polymerase II during the Cell Cycle

Cell Rep. 2017 Dec 19;21(12):3483-3497. doi: 10.1016/j.celrep.2017.11.090.

Abstract

MYC proteins bind globally to active promoters and promote transcriptional elongation by RNA polymerase II (Pol II). To identify effector proteins that mediate this function, we performed mass spectrometry on N-MYC complexes in neuroblastoma cells. The analysis shows that N-MYC forms complexes with TFIIIC, TOP2A, and RAD21, a subunit of cohesin. N-MYC and TFIIIC bind to overlapping sites in thousands of Pol II promoters and intergenic regions. TFIIIC promotes association of RAD21 with N-MYC target sites and is required for N-MYC-dependent promoter escape and pause release of Pol II. Aurora-A competes with binding of TFIIIC and RAD21 to N-MYC in vitro and antagonizes association of TOP2A, TFIIIC, and RAD21 with N-MYC during S phase, blocking N-MYC-dependent release of Pol II from the promoter. Inhibition of Aurora-A in S phase restores RAD21 and TFIIIC binding to chromatin and partially restores N-MYC-dependent transcriptional elongation. We propose that complex formation with Aurora-A controls N-MYC function during the cell cycle.

Keywords: Aurora-A; MYC; N-MYC; RAD21; TFIIIC; neuroblastoma; pause release.

MeSH terms

  • Aurora Kinase A / metabolism*
  • Cell Cycle Proteins
  • Cell Line, Tumor
  • DNA Topoisomerases, Type II / metabolism
  • DNA, Intergenic / metabolism
  • DNA-Binding Proteins
  • Humans
  • N-Myc Proto-Oncogene Protein / metabolism*
  • Nuclear Proteins / metabolism
  • Phosphoproteins / metabolism
  • Promoter Regions, Genetic
  • Protein Binding
  • RNA Polymerase II / genetics
  • RNA Polymerase II / metabolism*
  • S Phase*
  • Transcription Elongation, Genetic
  • Transcription Factors, TFIII / metabolism

Substances

  • Cell Cycle Proteins
  • DNA, Intergenic
  • DNA-Binding Proteins
  • N-Myc Proto-Oncogene Protein
  • Nuclear Proteins
  • Phosphoproteins
  • RAD21 protein, human
  • Transcription Factors, TFIII
  • transcription factor TFIIIC
  • Aurora Kinase A
  • RNA Polymerase II
  • DNA Topoisomerases, Type II